AI - BenevolentAI
Revolutionizing drug discovery through advanced AI technologies with BenevolentAI's vast data analysis capabilities and commitment to ESG initiatives.
- Name
- BenevolentAI -https://www.benevolent.com/
- Last Audited At
About BenevolentAI
BenevolentAI is a pioneering technology company located at the Babraham Campus in Cambridge, UK, and has additional offices in London, New York, and Luxembourg. The team at BenevolentAI is dedicated to revolutionizing the way drugs are discovered and developed through advanced artificial intelligence (AI) technologies.
They employ cutting-edge AI systems, including their Benevolent Platform and BenAI Engine, to analyze vast amounts of scientific data and literature, accelerating the drug discovery process and providing new insights into potential treatments for various diseases. Their AI principles, commitment to Environmental, Social, and Governance (ESG) initiatives, and Data Diversity Initiative reflect their core values and mission to make a positive impact on society.
Investors interested in BenevolentAI can find relevant information on their investor relations page, including investor presentations, annual reports, governance, and events. The company is registered under R.C.S. Luxembourg: B255412. For further inquiries or collaboration opportunities, potential partners are encouraged to reach out using the provided contact information.
